Renal function and cardiovascular risk markers in a remote Australian Aboriginal community

Nephrology Dialysis Transplantation

Volumn 18, Issue 8, 2003, Pages 1555-1561

  McDonald, Stephen P ^a   Maguire, Graeme P ^a,b   Hoy, Wendy E ^a,c  

^a FLINDERS UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Albuminuria; Australian Aborigines; Cardiovascular disease; Cardiovascular markers; End stage renal disease

Indexed keywords

CREATININE; HEMOGLOBIN A1C; LIPID;

ABORIGINE; ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HEALTH SURVEY; HUMAN; INCIDENCE; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; LIPID BLOOD LEVEL; MALE; MICROALBUMINURIA; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEINURIA; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; CARDIOVASCULAR DISEASES; CREATININE; CROSS-SECTIONAL STUDIES; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; NORTHERN TERRITORY; OCEANIC ANCESTRY GROUP; RISK FACTORS;

EID: 0042164583     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfg199     Document Type: Article

References (24)

1. Mann JF, Gerstein HC, Pogue J, Bosch J, Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 2001; 134: 629-636
2. Beddhu S, Allen-Brady K, Cheung AK et al. Impact of renal failure on the risk of myocardial infarction and death. Kidney Int 2002; 62: 1776-1783
3. Jensen JS, Feldt-Rasmussen B, Borch-Johnsen K, Jensen G. Urinary albumin excretion in a population based sample of 1011 middle aged non-diabetic subjects. The Copenhagen City Heart Study Group. Scand J Clin Lab Invest 1993; 53: 867-872
4. Valmadrid CT, Klein R, Moss SE, Klein BE. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch Intern Med 2000; 160: 1093-1100
5. Roest M, Banga JD, Janssen WM et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation 2001; 103: 3057-3061
6. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310: 356-360
7. Dell'Omo G, Penno G, Giorgi D, di Bello V, Mariani M, Pedrinelli R. Association between high-normal albuminuria and risk factors for cardiovascular and renal disease in essential hypertensive men. Am J Kidney Dis 2002; 40: 1-8
8. Kristjansson K, Ljungman S, Bengtsson C, Bjorkelund C, Sigurdsson JA. Microproteinuria and long-term prognosis with respect to renal function and survival in normotensive and hypertensive women - a 24-year follow-up of a representative population sample of women in Gothenburg, Sweden. Scand J Urol Nephrol 2001; 35: 63-70
9. Hoy W, Wang Z, van Buynder P, Baker P, McDonald S, Mathews J. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int 2001; 60: 249-256
10. Cass A, Cunningham J, Wang Z, Hoy W. Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust 2001; 175: 24-27
11. Hoy WE, Mathews JD, McCredie DA et al. The multi-dimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296-1304
12. Guest CS, Ratnaike S, Larkins RG. Albuminuria in aborigines and Europids of south-eastern Australia. Med J Aust 1993; 159: 335-338
13. Rowley KG, Iser DM, Best JD, O'Dea K, Leonard D, McDermott R. Albuminuria in Australian Aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia 2000; 43: 1397-1403
14. Dempsey K, Condon J. Mortality in the Northern Territory 1979-1997, 1st edn. Territory Health Services, Darwin, 1999
15. Hoy W, Wang Z, van Buynder P, Baker P, Mathews J. The natural history of renal disease: Part 1. Changes in albuminuria and glomerular filtration rate over time in a community-based cohort of Australian Aborigines with high rates of renal disease. Kidney Int 2001; 60: 243-248
16. Jones CO, White NG. Adiposity in aboriginal people from Arnhem Land, Australia: variation in degree and distribution associated with age, sex and lifestyle. Ann Hum Biol 1994; 21: 207-227
17. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
18. American Diabetes Association and the National Kidney Foundation. Consensus development conference on the diagnosis and management of nephropathy in patients with diabetes mellitus. Diabetes Care 1994; 17: 1357-1361
19. Cundy TF, Nixon D, Berkahn L, Baker J. Measuring the albumin excretion rate: agreement between methods and biological variability. Diabet Med 1992; 9: 138-143
20. Atkins R, Briganti E, Shaw J, Zimmet P, Chadban S. Albuminuria and proteinuria - do they mean the same thing? Nephrology 2002; 7: A65
21. Dunstan D, Zimmet P, Welborn T et al. on behalf of the AusDiab Steering Committee. Diabetes and Associated Disorders in Australia 2000. The Accelerating Epidemic. Australian Diabetes, Obesity & Lifestyle Study (AusDiab). International Diabetes Institute, Melbourne, 2001
22. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, Schroll M, Jensen JS. Urinary albumin excretion. An independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19: 1992-1997
23. Atchley DH, Lopes-Virella MF, Zheng D, Kenny D, Virella G. Oxidized LDL-anti-oxidized LDL immune complexes and diabetic nephropathy. Diabetologia 2002; 45: 1562-1571
24. Bayes B, Pastor MC, Bonal J et al. Homocysteine, C-reactive protein, lipid peroxidation and mortality in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 106-112